Clinical Trial Details
— Status: Completed
Administrative data
NCT number |
NCT04753333 |
Other study ID # |
DSRMajmaahU |
Secondary ID |
2020-26 |
Status |
Completed |
Phase |
N/A
|
First received |
|
Last updated |
|
Start date |
November 30, 2020 |
Est. completion date |
February 28, 2021 |
Study information
Verified date |
September 2021 |
Source |
Majmaah University |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Interventional
|
Clinical Trial Summary
This study aims to investigate the effects of electromyography biofeedback (EMG-BF) guided
isometric quadriceps strengthening with patellar taping and isometric exercise alone in young
adult male athletes with patellofemoral pain syndrome (PFPS).
Description:
A total of 60 adult male athletes aged 18 to 45 years will be recruited from two cities
(Majmaah and Riyadh) of Saudi Arabia. Subjects will be included with the history of knee pain
during activities such as descending and ascending stairs, squatting, and running, had
positive J sign (lateral tilt of patella), and a sign of patellar malalignment on the
radiograph. Individuals with the history of fracture around knee, patella dislocation, knee
deformity (e.g., genu varum), flexion contracture, ligaments/meniscal injuries, and
osteoarthritis of knee will be excluded from the study. The protocol was submitted to and
approved by the ethical sub-committee of College of applied medical science, Majmaah, Saudi
Arabia (Ethics number: MUREC-Nov./COM-2O20/11-2). Participants will be requested to sign a
written informed consent form approved by the institution ethics committee.
Participants will be randomly assigned to Group A (experimental group): electromyography
biofeedback (EMG-BF) guided maximum voluntary isometric contraction exercise with patellar
taping; Group B (control group): sham EMG-BF guided maximum voluntary isometric contraction
without patellar taping. The outcome measure for this study will be the mean changes in
maximum voluntary isometric contraction (MVIC) of the quadriceps muscle, pain intensity, and
functional status up to 6 weeks.